172 related articles for article (PubMed ID: 1347057)
1. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.
Carvalho EM; Barral A; Pedral-Sampaio D; Barral-Netto M; Badaró R; Rocha H; Johnson WD
J Infect Dis; 1992 Mar; 165(3):535-40. PubMed ID: 1347057
[TBL] [Abstract][Full Text] [Related]
2. Gamma interferon production by lymphocytes from children infected with L. chagasi.
Bacellar O; Barral-Netto M; Badaró R; Carvalho EM
Braz J Med Biol Res; 1991; 24(8):791-5. PubMed ID: 1797267
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
[TBL] [Abstract][Full Text] [Related]
4. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
[TBL] [Abstract][Full Text] [Related]
5. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
Tripathi P; Ray S; Sunder S; Dube A; Naik S
Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
[TBL] [Abstract][Full Text] [Related]
6. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi.
Holaday BJ; Pompeu MM; Evans T; Braga DN; Texeira MJ; Sousa Ade Q; Sadick MD; Vasconcelos AW; Abrams JS; Pearson RD
J Infect Dis; 1993 Feb; 167(2):411-7. PubMed ID: 8421174
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
8. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.
White AC; Castes M; Garcia L; Trujillo D; Zambrano L
Am J Trop Med Hyg; 1992 Feb; 46(2):123-31. PubMed ID: 1539745
[TBL] [Abstract][Full Text] [Related]
9. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.
Garg R; Gupta SK; Tripathi P; Naik S; Sundar S; Dube A
Clin Exp Immunol; 2005 Apr; 140(1):149-56. PubMed ID: 15762886
[TBL] [Abstract][Full Text] [Related]
11. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
[TBL] [Abstract][Full Text] [Related]
12. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis in vervet monkeys: immunological responses during asymptomatic infections.
Gicheru MM; Olobo JO; Kariuki TM; Adhiambo C
Scand J Immunol; 1995 Feb; 41(2):202-8. PubMed ID: 7863267
[TBL] [Abstract][Full Text] [Related]
15. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
17. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi.
dos Santos JI; Morgado MG; Galvão-Castro B
Am J Trop Med Hyg; 1987 Sep; 37(2):263-70. PubMed ID: 2444121
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
19. Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients.
Meller-Melloul C; Farnarier C; Dunan S; Faugere B; Franck J; Mary C; Bongrand P; Quilici M; Kaplanski S
Parasite Immunol; 1991 Sep; 13(5):531-6. PubMed ID: 1956699
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
